Kindred Healthcare Announces Fourth Quarter Results And Plans For Ventas Lease Renewals
Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced its operating results for the fourth quarter and year ended December 31, 2011 as well as its intentions with respect to the renewal of facility leases with its primary landlord, Ventas, Inc. (“Ventas”) (NYSE:VTR). The Company’s consolidated financial statements include the operating results of RehabCare Group, Inc. (“RehabCare”) since the closing of the acquisition on June 1, 2011.
Highlights (operating data adjusted to exclude certain items):
-
Favorable impact of RehabCare acquisition negated by fourth quarter
regulatory changes
- Initial quarter under new RUGs IV and rehabilitation therapy rule changes more challenging than expected
- Annual impact of new Medicare rules now estimated at $150 million
-
Fourth quarter consolidated continuing operations key metrics compared
to last year
- Revenues grew 34% to $1.5 billion
- Operating income rose 25% to $200 million
- Income from continuing operations fell 35% to $14 million
- Diluted earnings per share declined 50% to $0.27
-
Fourth quarter operating summary
- Hospital revenues rose 40%; same-store revenues increased 5% while admissions rose 4%
- Medicare cuts materially hampered nursing center and rehabilitation therapy results
- Home health and hospice business reported strong results
-
Company continues to generate significant operating cash flows
- Excluding transaction-related payments, full year operating cash flows grew 11% to $238 million
-
Company reduces 2012 earnings guidance
- RehabCare synergy estimate rises to $70 million from $62 million
- Company expects to implement $50 million to $55 million of additional cost reductions
-
Company expects non-renewal of seven Ventas bundles containing 64
facilities in April 2013
- Future growth prospects for these facilities considered limited
- Many of the facilities do not align with the Company’s operating plan and cluster market strategy
- Expected 2013 EPS dilution of $0.10 to $0.15 from these divestitures considered manageable
- Divestitures will improve the Company’s capital structure over the long term
Fourth Quarter Results
Continuing Operations
Consolidated revenues for the fourth quarter ended December 31, 2011 increased 34% to $1.5 billion compared to $1.1 billion in the same period in 2010. The Company reported a loss from continuing operations for the fourth quarter of 2011 of $72.8 million or $1.42 per diluted share compared to income of $19.7 million or $0.50 per diluted share in the fourth quarter of 2010. Operating results for the fourth quarter of 2011 included asset impairment charges, transaction-related costs and a loss on a hospital divestiture that reduced income from continuing operations by $86.7 million or $1.69 per diluted share. Operating results for the fourth quarter of 2010 included transaction-related costs that reduced income from continuing operations by $1.6 million or $0.04 per diluted share.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
